Vanessa Strings-Ufombah

Vanessa Strings-Ufombah is a prominent inventor based in Hayward, CA (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of oculopharyngeal muscular dystrophy (OPMD). With a total of 3 patents to her name, her work is paving the way for innovative treatments in genetic disorders.

Latest Patents

Her latest patents include groundbreaking research on reagents for the treatment of OPMD. The first patent focuses on RNA interference (RNAi) reagents, such as short hairpin microRNA (shmiR) and short hairpin RNA (shRNA), which are designed to treat individuals suffering from OPMD or those predisposed to it. This patent also discusses the use of RNAi reagents in combination with PABPN1 replacement reagents, which encode functional PABPN1 protein for effective treatment.

The second patent involves modified adeno-associated virus (AAV) from serotypes other than serotype 2. This innovation includes a viral capsid protein with a modified phospholipase A2 (PLA2) domain, which enhances the functionality of the AAV when produced in insect cells. The patent outlines methods for producing these modified AAVs, along with the necessary reagents and expression systems.

Career Highlights

Vanessa is currently employed at Benitec IP Holdings, Inc., where she continues to advance her research in gene therapy. Her work is characterized by a commitment to developing effective treatments for genetic disorders, showcasing her dedication to improving patient outcomes.

Collaborations

Some of her notable coworkers include David A Suhy and Shih-Chu Kao, who contribute to her innovative projects and research endeavors.

Conclusion

Vanessa Strings-Ufombah is a trailblazer in the field of gene therapy, with her patents reflecting her innovative spirit and dedication to medical advancements. Her contributions are vital in the ongoing quest to find effective treatments for genetic disorders.